Despite being less common than other types of psychiatric disorders, schizophrenia contributes substantially to global estimates of disability. Almost 3 million Americans live with the illness in a given year (Torrey & Sinclair, 2018). There is reason for optimism for people with schizophrenia spectrum disorders and their families. Research has led to more effective medication approaches and continues to develop newer types of medications; at the same time, researchers are unraveling the complex causes of these disorders. The outlook for people with schizophrenia has improved over the last 25 years. Although there is no cure yet, it is important to remember that many people can manage the illness to lead independent, satisfying lives. The main goal of this course is to provide you with the information and current research you need to better understand how to collaborate in the treatment of schizophrenia spectrum disorders.
As a Jointly Accredited organization, Relias LLC is approved to offer co-sponsored psychology continuing education by the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA is an associate member of Joint Accreditation for Interprofessional Continuing Education.
Provider approved by the California Board of Registered Nursing, CEP# 13791
Nurses will receive 1.75 contact hours for participating in this course.
District of Columbia Board of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Florida Board of Clinical Social Work, Marriage and Family Therapy and Mental Health Counseling (CEBroker Provider #50-290)
This activity is approved for 1.75 contact hours.
Relias, LLC has been approved by NBCC as an Approved Continuing Education Provider, ACEP No.6110. Programs that do not qualify for NBCC credit are clearly identified. Relias , LLC is solely responsible for all aspects of the programs. This activity is approved for 1.5000 contact hours.
Ohio Counselor, Social Worker and Marriage and Family Therapist Board
Provider # RTX050401 (CEBroker Provider 50-290)
Ohio Counselor, Social Worker and Marriage and Family Therapist Board
Provider # RCX100502 (CEBroker Provider: 50-290)
Ohio Counselor, Social Worker and Marriage and Family Therapist Board (CEBroker Provider # 50-290)
Florida Board of Nursing (CEBroker Provider #50-290)
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
As a Jointly Accredited Organization, Relias LLC is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Relias LLC maintains responsibility for this course. Social workers completing this course receive 1.75 Clinical continuing education credits.
Relias, LLC is recognized by the New York State Education Department's State Board for Social Work as an approved provider of continuing education for licensed social workers #SW-0009.
Materials that are included in this course may include interventions and modalities that are beyond the authorized practice of licensed master social work and licensed clinical social work in New York. As a licensed professional, you are responsible for reviewing the scope of practice, including activities that are defined in law as beyond the boundaries of practice for an LMSW and LCSW. A licensee who practices beyond the authorized scope of practice could be charged with unprofessional conduct under the Education Law and Regents Rules.
As a provider of online, asynchronous education, some courses offered by Relias Learning are considered “self-study” under section 74.10(c)(2)(ii)(b)(4) of the Commissioner’s Regulations. The regulations limit self-study activities taken from a provider approved by the Education Department to no more than 12 hours in the 36-month registration period or one-third of the hours in a registration period other than 36 months.
Social workers will receive 1.75 continuing education hours for participating in this course. This activity is approved for 1.75 contact hours.
Florida Board Of Psychology (CEBroker Provider #50-290)
Georgia Board of Nursing (CEBroker Provider #50-290)
This activity is approved for 1.75 contact hours.
Relias, LLC, is recognized by New York State Education Department's State Board for Mental Health Practitioners as an approved provider of continuing education for licensed mental health counselors. #MHC-0011
As a provider of online, asynchronous education, some courses offered by Relias, LLC are considered "self-study". The regulations limit self-study activities taken from a provider approved by the Education Department to no more than 12 hours in the 36-month registration period or one-third of the hours in a registration period other than 36 months.
This activity is approved for 1.75 contact hours.
Relias, LLC, is recognized by New York State Education Department's State Board for Mental Health Practitioners as an approved provider of continuing education for Licensed Marriage and Family Therapists. #MFT-0009
As a provider of online, asynchronous education, some courses offered by Relias are considered "self-study". The regulations limit self-study activities taken from a provider approved by the Education Department to no more than 12 hours in the 36-month registration period or one-third of the hours in a registration period other than 36 months.
This activity is approved for 1.75 contact hours.
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
South Carolina Board of Nursing (CEBroker Provider #50-290)
Florida Board of Medicine (CEBroker Provider #50-290)
Physicians will receive 1.75 AMA PRA category 1 Credits™.
Florida Physician Assistants (CEBroker Provider #50-290)
West Virginia Board of Registered Nursing (CEBroker Provider #50-290)
New Mexico Board of Nursing (CEBroker Provider #50-290)
Arkansas State Board Of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Louisiana State Board of Medical Examiners (CEBroker Provider #: 50-290)
Mississippi State Board of Medical Licensure (CEBroker Provider #: 50-290)
South Carolina Board of Social Work Examiners (CEBroker Provider 50-290)
Ohio Chemical Dependency Professionals Board (CEBroker Provider #50-290)
This activity is approved for 1.7500 contact hours.
This activity is approved for 1.75 contact hours.
Education hours MCBAP-R
This activity is approved for 1.75 contact hours.
This course has been approved by Relias LLC, as a NAADAC Approved Education Provider, for 1.75 CE. NAADAC Provider #86124, Relias, LLC is responsible for all
aspects of their programming.
This activity is approved for 1.75 contact hours.
Provider approved by CCAPP, Provider number 1S-06-729-0220 for 1.75 CEH's
This activity is approved for 1.75 contact hours.
This activity is approved for 1.75 contact hours.
This activity is approved for 1.75 contact hours.
Categories Counselor I or II, Preventionist I or II, CARS I or II, CODP I or II, PCGC II, CCJP II, CAAP I, CRSS I or II, CPRS I or II, MAATP I or II, NCRS II, CFPP II, CVSS II
This activity is approved for 1.75 contact hours.
This activity is approved for 1.75 contact hours.
Outline:
Section 1: Introduction
About This Course
Learning Objectives
Section 2: Treatment Approaches
Schizophrenia As a Group of Syndromes
Symptoms That are Addressed
Treatment and Rehabilitation of Schizophrenia
Medication
Prognosis and Course
Typical Antipsychotic Medications
Atypical Antipsychotics
Other Atypical Antipsychotics
Dosages and Method of Delivery
Injectable Antipsychotics
Medication Efficacy
Course of Treatment
Misconceptions about Antipsychotics
Other Treatments
Review
Summary
Section 3: Medication Side Effects
Meet Jerome
Side Effects
What Are Extrapyramidal Symptoms?
Medication-Induced Dystonia
Medication-Induced Dyskinesia
Medication-Induced Akathisia
Medication-Induced Parkinsonism (Pseudoparkinsonism)
Other Terms Associated with EPS
Prevalence Rates of Medication-Induced Movement Disorders
Diagnosing Movement Symptoms
What Do Movement Symptoms Look Like?
Neuroleptic Malignant Syndrome
Clozapine
Metabolic Side Effects
Metabolic Screening
Medication Risks and Selection
Avoiding Side Effects
Minimizing or Reversing Side Effects
Review
Summary
Section 4: Conclusion
Summary
Course Contributors
Resources
References
Congratulations!
Monique Kahn, Psy.D. received her doctoral degree in Clinical Psychology from Nova Southeastern University in Florida. She completed a pre-doctoral internship at Spokane Mental Health in Washington, which included specialty rotations in behavioral medicine and time-limited psychotherapies. She is licensed as a psychologist in Maine, where she was in private practice for 14 years, providing services to adult clients with varied presenting issues, but with particular emphasis on the treatment of anxiety disorders, the relationship between psychosocial stress and illness, insomnia, and coping with chronic illness. She has taught in the undergraduate psychology program at Husson University in Maine. In addition, she has worked as a content writer and psychology subject matter expert for several major educational publishing firms. She joined Relias as a clinical content writer and subject matter expert in 2016. Disclosure: Monique Kahn, Psy.D. has declared that no conflict of interest, Relevant Financial Relationship or Relevant Non-Financial Relationship exists.Expert Reviewer: John Cahill, MD, PhD
Dr. Cahill has experience in community psychiatry across both the UK and US healthcare systems. He specializes in building Learning Health Systems for early intervention and 'safety net' behavioral health services - towards better-value, person-centered, integrated care for individuals with severe mental illness and co-occurring substance use disorders. After completing medical school in the UK, Dr. Cahill undertook both psychiatry residency and advanced clinical research fellowships at Yale, with a focus on knowledge translation, from the community to the lab, and vice versa, particularly in the study and management of psychotic disorders and their complex interaction with cannabinoids. He is board-certified in Psychiatry and Addiction Medicine. His work is founded on respect for the patient and caregiver experience, addressing the whole person, judicious prescribing practices and embracing a complex adaptive system perspective. His research interests involve using unifying principles and translational approaches to develop novel biomarkers, treatments, technologies, clinical guidelines and resident curricula for the care of psychotic disorders. He is faculty of both Yale School of Medicine and Yale School of Nursing. Disclosure: John Cahill, MD, PhD has declared that no conflict of interest, Relevant Financial Relationship or Relevant Non-Financial Relationship exists.
Access to over 1,450 courses! Access to 1,450+ courses for one low price.